ABOUT THE EVENT
The 2026 Critical Path Institute® (C-Path) Global Impact Conference (CGIC) brings together leaders from academia, industry, regulatory agencies, patient organizations, and nonprofit research to advance a shared goal: making drug development more efficient, evidence-driven, and responsive to patient needs.
As you’ve come to expect from previous years, this event will offer the chance to collaborate on the next wave of innovative therapies, discuss the latest initiatives, network with colleagues, and drive progress for those that need it most: people living with unmet medical needs.
If you’re part of the movement to improve drug development with accelerated timelines and custom therapies, CGIC 2026 is the event you can’t afford to miss. You’ll have two full days to engage in inspiring conversations, discover the latest developments in neurology, rare diseases, pediatrics, and explore the newest tools and collaborations C-Path has to offer.
From Insight to Impact: Voices from the Frontlines of Drug Development
Hear perspectives from leaders across the C-Path community on what it takes to accelerate progress and why collaboration is essential to meeting the evolving needs of patients and developers today.
"Speaker quality was superb, and the venue and staff were amazing."
"I found all sessions interesting and relevant. I also commend the inclusion of the patient-perspective in each session."
"It was a great opportunity to think at not only a higher level, but long term about today's drug development needs. Hearing about innovations from many people was great too."
Registration Details
Online registration will close on September 11, 2026, 4:59 p.m. EST
Additional Session: RDCA-DAP Workshop
Register Here for the RDCA-DAP Workshop
Title: Got Data? Evaluating Real-World Data Suitability to Inform Regulatory Decision-Making
When: Monday, September 14, 9 am – 12:30 pm EST
Participants: the workshop is intended for stakeholders across industry, academia, patient organizations, and regulatory bodies seeking to advance the generation and use of RWD to support regulatory decision-making. Outcomes include a shared approach to early feasibility assessment and actionable insights to guide future RWD collection and curation strategies.
Sponsored by:
Counting down to CGIC 2026
- Days10
- Hours14
- Minutes41